High expression of ezrin predicts poor prognosis in uterine cervical cancer

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Kong, Jienan ^a,b   Li, Yan ^c   Liu, Shuangping ^a,b   Jin, Haidan ^a,b   Shang, Yongjun ^a,d   Quan, Chengshi ^e   Li, Yulin ^e   Lin, Zhenhua ^a,b  

^a YANBIAN UNIVERSITY   (China)

^b YANBIAN UNIVERSITY MEDICAL COLLEGE   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d Chifeng University   (China)

^e JILIN UNIVERSITY   (China)

Author keywords

Ezrin; Human papillomavirus; Survival analysis; Uterine cervical cancer

Indexed keywords

EZRIN; MESSENGER RNA;

ADULT; AGED; APICAL MEMBRANE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ELECTROSURGERY; FEMALE; GENE OVEREXPRESSION; GENOTYPE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PREDICTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PUNCH BIOPSY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR DIFFERENTIATION; UTERINE CERVIX; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; AGED; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; PROTEIN TRANSPORT; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84886732410     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-520     Document Type: Article

References (38)

1. Li Q, Gao H, Xu H, Wang X, Pan Y, Hao F, Qiu X, Stoecker M, Wang E, Wang E. Expression of Ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of Ezrin reverses the aggressive biological behavior of lung cancer cells. Tumour Biol 2012, 33(5):1493-504.
2. Neisch AL, Fehon RG. Ezrin, Radixin and Moesin: key regulators of membrane-cortex interactions and signaling. Curr Opin Cell Biol 2011, 23(4):377-382.
3. Huang HY, Li CF, Fang FM, Tsai JW, Li SH, Lee YT, Wei HM. Prognostic implication of Ezrin overexpression in myxofibrosarcomas. Ann Surg Oncol 2010, 17(12):3212-3219.
4. Fehon RG, McClatchey AI, Bretscher A. Organizing the cell cortex: the role of ERM proteins. Nat Rev Mol Cell Biol 2010, 11(4):276-287.
5. Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 2002, 3(8):586-599.
6. Gautreau A, Louvard D, Arpin M. Morphogenic effects of ezrin require a phosphorylation-induced transition from oligomers to monomers at the plasma membrane. J Cell Biol 2000, 150(1):193-203.
7. Hiscox S, Jiang WG. Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/beta-catenin. J Cell Sci 1999, 18:3081-3090.
8. Ohtani K, Sakamoto H, Rutherford T, Chen Z, Satoh K, Naftolin F. Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Cancer Lett 1999, 147(1-2):31-38.
9. Yasuoka H, Tsujimoto M, Inagaki M, Kodama R, Tsuji H, Iwahashi Y, Mabuchi Y, Ino K, Sanke T, Nakamura Y. Clinicopathological significance of podocalyxin and phosphorylated ezrin in uterine endometrioid adenocarcinoma. J Clin Pathol 2012, 65(5):399-402.
10. Köbel M, Gradhand E, Zeng K, Schmitt WD, Kriese K, Lantzsch T, Wolters M, Dittmer J, Strauss HG, Thomssen C, Hauptmann S. Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis of ovarian carcinoma. Int J Gynecol Pathol 2006, 25(2):121-130.
11. Kocher HM, Sandle J, Mirza TA, Li NF, Hart IR. Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells. Gut 2009, 58(2):271-284.
12. Cui Y, Li T, Zhang D, Han J. Expression of Ezrin and phosphorylated Ezrin (pEzrin) in pancreatic ductal adenocarcinoma. Cancer Invest 2010, 28(3):242-247.
13. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ. The membrane-cytoskeleton linker Ezrin is necessary for osteosarcoma metastasis. Nat Med 2004, 10(2):182-186.
14. Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, Trepel J, Meltzer P, Helman L. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 2001, 61(9):3750-3759.
15. Li Q, Wu M, Wang H, Xu G, Zhu T, Zhang Y, Liu P, Song A, Gang C, Han Z, Zhou J, Meng L, Lu Y, Wang S, Ma D. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells. Cancer Lett 2008, 261(1):55-63.
16. Tavassoli FA, Devilee P. World Health Organization Classification of Tumors, Pathology & Genetics Tumours of the Breast and Female Genital Organs 2003, Lyon: IARC Press.
17. Elzagheid A, Korkeila E, Bendardaf R, Buhmeida A, Heikkilä S, Vaheri A, Syrjänen K, Pyrhönen S, Carpén O. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Hum Pathol 2008, 39(12):1737-1743.
18. Jin J, Jin T, Quan M, Piao Y, Lin Z. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma. Diagn Pathol 2012, 7:135.
19. Zhao Y, Lin H, Shen D, Xuan Y, Lin Z. Distribution of HPV genotypes in uterine cervical lesions in Yanbian, northern China. Pathol Int 2008, 58(10):643-647.
20. Lee MY, Shen MR. Epithelial-mesenchymal transition in cervical carcinoma. Am J Transl Res 2012, 4(1):1-13.
21. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003, 16(1):1-17.
22. Das P, Thomas A, Mahantshetty U, Shrivastava SK, Deodhar K, Mulherkar R. HPV genotyping and site of viral integration in cervical cancers in Indian women. PLoS One 2012, 7(7):e41012.
23. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006, 12(8):895-904.
24. Fievet B, Louvard D, Arpin M. ERM proteins in epithelial cell organization and functions. Biochim Biophys Acta 2007, 1773(5):653-660.
25. Arslan AA, Silvera D, Arju R, Giashuddin S, Belitskaya-Levy I, Formenti SC, Schneider RJ. Atypical ezrin localization as a marker of locally advanced breast cancer. Breast Cancer Res Treat 2012, 134(3):981-988.
26. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G. Expression profiling identifies the cytoskeletal organizer Ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 2004, 10(2):175-181.
27. Sarrió D, Rodríguez-Pinilla SM, Dotor A, Calero F, Hardisson D, Palacios J. Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas. Breast Cancer Res Treat 2006, 98(1):71-79.
28. Cui Y, Wu J, Zong M, Song G, Jia Q, Jiang J, Han J. Proteomic profiling in pancreatic cancer with and without lymph node metastasis. Int J Cancer 2009, 124(7):1614-1621.
29. Tan J, Zhang C, Qian J. Expression and significance of Six1 and Ezrin in cervical cancer tissue. Tumor Biol 2011, 32(6):1241-1247.
30. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N EngI J Med 2003, 348(6):518-527.
31. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006, 44(2):504-512.
32. Guo M, Sneige N, Silva EG, Jan YJ, Cogdell DE, Lin E, Luthra R, Zhang W. Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod Pathol 2007, 20(2):256-266.
33. Krul EJ, Van De Vijver MJ, Schuuring E, Van Kanten RW, Peters AA, Fleuren GJ. Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk country. Int J Gynecol Cancer 1999, 9(3):206-211.
34. Lin ZH, Shen XH, Jin Z, Kim Y, Lee E, Kim H, Kim I. Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women. Pathol Int 2005, 55(8):491-496.
35. Qian K, Pietilä T, Rönty M, Michon F, Frilander MJ, Ritari J, Tarkkanen J, Paulín L, Auvinen P, Auvinen E. Identification and Validation of Human Papillomavirus Encoded microRNAs. PLoS One 2013, 8(7):e70202.
36. Greco D, Kivi N, Qian K, Leivonen SK, Auvinen P, Auvinen E. Human papillomavirus 16 E5 modulates the expression of host microRNAs. PLoS One 2011, 6(7):e21646.
37. Auvinen E, Carpen O, Korpela T, Ronty M, Vaheri A, Tarkkanen J. Altered expression of ezrin, E-Cadherin and β-Catenin in cervical neoplasia. Neoplasma 2013, 60(1):56-61.
38. Geiger T, Sabanay H, Kravchenko-Balasha N, Geiger B, Levitzki A. Anomalous features of EMT during keratinocyte transformation. PLoS One 2008, 3(2):e1574.